Serum Free Light Chain (sFLC) Assays Market Size, Share & Industry Analysis, By Technique (Latex Nephelometric/Turbiometric and ELISA), By Indication (Multiple Myeloma, Light Chain Amyloidosis, and Others), By End-user (Hospital Laboratories, Clinical & Pathology Laboratories, and Others), and Regional Forecast, 2024-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI102087

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Unit	Value (USD Million)
Growth Rate	CAGR of 8.6% from 2024-2032
Segmentation	By Technique Latex Nephelometric/Turbiometric ELISA
	By Indication Multiple Myeloma Light Chain Amyloidosis Others
	By End User Hospital Laboratories Clinical & Pathology Laboratories Others
	By Region North America (By Technique, Indication, End-user, and Country) U.S. Canada Europe (By Technique, Indication, End-user, and Country) U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Technique, Indication, End-user, and Country) Japan China India Australia Southeast Asia Rest of Asia Pacific Rest of the World (By Technique, Indication, and End-user)